InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Rosen Hugh. Director active across 1 company, notably Regulus Therapeutics Inc.. Aggregated, 1 filings have been published. History available since 30 April 2025. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration